CDKN1B and hepatocellular carcinoma: The AMPK activator metformin partially offset the PCK1 deficiency-mediated downregulation of p27Kip1, upregulation of pRb, promotion of G1/S transition, and acceleration of hepatoma cell proliferation (Fig. 4, and Additional file 5: Figure S4b).